Vaccine Therapy in Treating Patients With Cancer of the Gastrointestinal Tract
Stopped early · Phase 2
Conditions studied: Colorectal Cancer, Esophageal Cancer, Extrahepatic Bile Duct Cancer, Gallbladder Cancer, Gastric Cancer, Pancreatic Cancer, Small Intestine Cancer
In brief
RATIONALE: Vaccines may make the body build an immune response to kill tumor cells. PURPOSE: Randomized phase II trial to compare the effectiveness of two different vaccines in treating patients who have cancer of the gastrointestinal tract.
Key facts
- Study ID
- NCT00012246
- Run by
- The University of Texas Medical Branch, Galveston
- People needed
- 7
- Starts
- 2002-07-01
- Expected to finish
- 2006-07-01
- Last updated by the study team
- 2013-05-16
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- University of Texas Medical Branch — Galveston, Texas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.